Innovate.

Incubate.

Accelerate.

Commercialize.

ResBiotech is an Innovation Institute for cardio-respiratory and maternal-child health technologies. 

Our world-class team and research partners are dedicated to the innovation, incubation, acceleration and commercialization of state of the art technologies with world-wide health impacts.

Drugs

Novel drugs for lung and
heart diseases

Devices

Smart devices for monitoring, diagnostics and management

Delivery

Top notch
health services

Data

Insights and
analytics for R&D

Our Process

Innovate: Cutting edge cardio-respiratory & maternal-child health research is both done in house and sourced from local and national partners.

Incubate: ResBiotech incubates scientific research with real world applications and zeroes in on market opportunity.

Accelerate: ResBiotech brings software and AI, data and analytics, licensing, regulatory, and other resources to bear to accelerate the path to market.

Commercialize: ResBiotech spins out state of the art technologies with worldwide health impacts and return on investment. 

A Platform for Commercialization and Spin-Offs

Starting with…

Resbiotic

Respiratory Probiotic and Pharmacobiotics

IoMT

Connected Ventilators,
Inhalers, Smart ICU

NeoZone

A Hub to Deliver Coaching and  Services for Caregivers

Insight

Benchmarking, National Registries, Outcome Prediction

Get Involved

Interested in

2 + 9 =